Sanofi Consumer Healthcare India

SANOFICONR.NS

Drug Manufacturers - General · Healthcare

Price

₹4567.20

+8.70 (+0.19%)

Market Cap

₹105.19B

Exchange

National Stock Exchange of India

Winston Score

Winston is curious

A decent business — some strong pillars, some weaker.

Sanofi Consumer Healthcare India Ltd. sells over-the-counter health products directly to everyday consumers in India. Its core brands include well-known products in vitamins, minerals, supplements, and digestive health — such as Combiflam (a pain reliever) and Allegra (an allergy medicine). The company is part of the global Sanofi group, one of the largest pharmaceutical companies in the world.

The company makes money by selling branded consumer health products through pharmacies, retail stores, and online channels across India. Its high gross margin reflects the pricing power that comes from owning trusted, recognizable brand names — a key competitive advantage in the Indian consumer health market. The main growth driver is India's expanding middle class and rising health awareness, which is increasing demand for self-care products. The main risk is competition from both large multinational brands and lower-cost local generic manufacturers eating into market share.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

75.5%

Premium pricing power — 75.5% gross margin

Operating Margin

37.3%

Excellent — 37.3% operating margin

ROCE

22.3%

Exceptional — 22.3% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

Data not available

EPS YoY

N/A

Data not available

EPS Consistency

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

68%

Modest — 68% of profit becomes cash

FCF Margin

17.9%

Converts sales into free cash efficiently (17.9%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

152.81x

Comfortably covers interest (152.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

40.8x

Pricey — P/E 40.8

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward

+3.0

GROWING

Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield

1.64%

Small dividend — 1.64% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial